The world cancer immunotherapy market is expected to grow at a CAGR of 11.4%
NEW YORK, March 4, 2019 /PRNewswire/ -- Monoclonal Antibodies, Cytokines & Immunomodulators, Immune Checkpoint Inhibitors, Cell Therapy, Oncolytic Virus Immunotherapy, Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, Hospitals, Cancer Research Centres, Clinics
Read the full report: https://www.reportlinker.com/p05748384
The world cancer immunotherapy market is expected to grow at a CAGR of 11.4% in the second half of the forecast period. The market reached $63bn in 2018, dominated by the monoclonal antibody segment which held 66% share of the market.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 194-page report you will receive 110 tables and 93 figures– all unavailable elsewhere.
The 194-page report provides clear detailed insight into the global cancer-treating drugs market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global cancer immunotherapy market forecasts from 2019-2029
This report also breaks down the revenue forecast for the global cancer immunotherapy market by Technology:
• Monoclonal Antibodies
• Cytokines & immunomodulators
• Others (Immune Checkpoint Inhibitors, Cell Therapy, Oncolytic Virus Immunotherapy)
Each submarket is further broken down by region: North America, South America, Europe, Asia-Pacific and ROW.
This report also breaks down the revenue forecast for the global cancer immunotherapy market by Application:
• Lung Cancer
• Breast Cancer
• Colorectal cancer
• Melanoma Cancer
• Prostate Cancer
• Head & Neck Cancer,
• Others (Renal Cell Carcinoma, Cervical, Gastric, Lymphoma)
Each submarket is further broken down by region: North America, South America, Europe, Asia-Pacific and ROW.
This report also breaks down the revenue forecast for the world cancer immunotherapy market by End-User:
• Hospitals
• Cancer Research Centers
• Clinics
Each submarket is further broken down by region: North America, South America, Europe, Asia-Pacific and ROW.
This report provides individual revenue forecasts to 2029 for these regional and national markets:
• North America: US, Canada, Mexico
• South America: Brazil, Argentina, Paraguay, Bolivia, Rest of South America
• Europe: The UK, Germany, France, Spain, Italy, Rest of Europe
• Asia-Pacific: China, Japan, India, Australia, Thailand, Rest of Asia-Pacific
• Rest of World: Middle East, Africa, Other Countries
Each regional market is further broken down by technology, application and end-user.
• This report discusses trends in the industry and assesses drivers and restraints, as well as opportunities and threats. It also includes porters' five force analysis; threat of new entrants, power of suppliers, power of buyers, rivalry among competitors and threat of substituents.
Our study discusses the selected leading companies that are the major players in the cancer immunotherapy market:
• Adaxic Inc
• AstraZeneca
• Bayer
• Bristol-Myers Squibb (BMS)
• Eli Lilly and Co.
• Medtronic Plc
• Merck & Co., Inc. (Merck)
• Novartis
• Pfizer
• Roche
The report provides overviews of the companies, financial information, product portfolio, pipeline products and recent developments.
Read the full report: https://www.reportlinker.com/p05748384
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article